Millions of Americans have tried GLP-1 medications like Ozempic, Mounjaro and Wegovy, polls show, but pharmacy claims data show that many people stop taking them within less than one year. There are ...
There is multidistrict litigation, or an MDL, in progress against pharmaceutical companies Novo Nordisk and Eli Lilly and Co. from parties allegedly suffering side effects caused by the active ...
With generic versions of the weight-loss drug Ozempic expected to hit the Canadian market this year, provincial data shows ...